New biomedical technologies are on the cusp of dramatically impacting not only healthcare and how we treat disease, but life itself. Visionary biologist, Andrew Hessel, spoke at our May What’s Now: San Francisco session exploring the extraordinary potential—and potential drawbacks—of gene editing and 3D printing in the field of biotech.
Related Resources
Healthcare at the Crossroads- the Emerging Business Model: A Point of View
Ideas and strategies that were ground-breaking before the pandemic are not suitable to deal...
Capgemini’s Retail Sustainability Solution “Circle”
Save time by not having to conduct a yard sale or take time posting and tracking online,...